2026-08-012 min
GHRH Analogues: Research Gaps Map and Evidence Boundaries
An evidence-led GHRH Analogues review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review DeskEvidence notes
Human studies, mechanisms, safety signals, regulatory status, and the limits of each conclusion.
Open
2026-08-012 min
GHRH Analogues: Glucose and Metabolic Context and Evidence Boundaries
An evidence-led GHRH Analogues review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-08-012 min
The CJC-1295 Human Trial: Study Design, Results and Limitations
A structured review of the landmark CJC-1295 healthy-adult trials, including endpoints, results, half-life and what the study cannot establish.
Reviewed by Endocrine Evidence Desk2026-07-312 min
GHRH Analogues: Healthy-Aging Claims and Evidence Boundaries
An evidence-led GHRH Analogues review focused on healthy-aging claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-312 min
GHRH Analogues: Sleep Claims and Evidence Boundaries
An evidence-led GHRH Analogues review focused on sleep claims, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-07-312 min
GHRH Analogues: Recovery and Injury Claims and Evidence Boundaries
An evidence-led GHRH Analogues review focused on recovery and injury claims, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-312 min
GHRH Analogues: Body Composition Claims and Evidence Boundaries
An evidence-led GHRH Analogues review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-312 min
CJC-1295 vs Sermorelin: Structure, Duration, Evidence and Approval History
Compare two GHRH receptor agonists by molecular design, duration, human evidence, historical approval and current regulatory status.
Reviewed by Regulatory Review Desk2026-07-302 min
GHRH Analogues: Adverse-Event Reporting and Evidence Boundaries
An evidence-led GHRH Analogues review focused on adverse-event reporting, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-302 min
GHRH Analogues: Small-Study Statistics and Evidence Boundaries
An evidence-led GHRH Analogues review focused on small-study statistics, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team